Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects (Q37275549)

19 August 2017

0 references

Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects (English)

1 reference

19 August 2017

0 references

0 references

0 references

1

Brian J Miller

1 reference

19 August 2017

Bintou Gassama

2

1 reference

19 August 2017

Dale Sebastian

series ordinal

3

1 reference

19 August 2017

Peter Buckley

series ordinal

4

1 reference

19 August 2017

Andrew Mellor

series ordinal

5

1 reference

19 August 2017

language of work or name

English

0 references

publication date

11 October 2012

1 reference

19 August 2017

Biological Psychiatry

1 reference

19 August 2017

73

1 reference

19 August 2017

10

1 reference

19 August 2017

993-999

1 reference

Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6.

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Disease-relevant autoantibodies in first episode schizophrenia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Cytokines and schizophrenia: Microglia hypothesis of schizophrenia.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Common variants on chromosome 6p22.1 are associated with schizophrenia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Common variants conferring risk of schizophrenia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Cigarette smoking and innate immunity

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Epidemiology of schizophrenia: review of findings and myths

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Stress, glucocorticoids and ageing of the immune system.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Mechanisms of relapse prevention in schizophrenia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Aspects of humoral and cellular immunity in schizophrenia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

The central nervous system--immune system relationship

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Effects of psychoactive drugs on in vitro lymphocyte activation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Leukocyte differentials predict short-term clinical outcome following antipsychotic treatment in schizophrenia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Neuroinflammation in schizophrenia-related psychosis: a PET study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Increased frequency of CD8 positive gamma/delta T-lymphocytes (CD8+ gamma/delta+) in unmedicated schizophrenic patients: relation to impairment of the blood-brain barrier and HLA-DPA*02011.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Immunological dysfunction in schizophrenia: a systematic approach

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Production of interferon-gamma in families with multiple occurrence of schizophrenia.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Assessment of lymphocyte subsets and neutrophil leukocyte function in chronic psychiatric patients on long-term drug therapy.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Clinical and laboratory evidence of autoimmunity in acute schizophrenia.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Increased numbers of CD5+ B lymphocytes in schizophrenic patients.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Lymphocyte subsets in schizophrenic disorders. Relationship with clinical, neuromorphological and treatment variables

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Correlation or coincidence between monocytosis and worsening of psychotic symptoms in veterans with schizophrenia?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Using bioinformatic tools

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

The influence of olanzapine on immune cells in patients with schizophrenia

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Neuroleptics normalize increased release of interleukin- 1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

Increased levels of CD8+ and CD4+ 45RA+ lymphocytes in schizophrenic patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816144

T-cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy

3 September 2018

1 reference

12 December 2020

CD5 positive B lymphocytes in schizophrenia: no alteration in numbers or percentage as compared with control subjects

1 reference

12 December 2020

T-cell subsets in acute psychotic schizophrenic patients

1 reference

12 December 2020

Changes of immunological functions after acute exacerbation in schizophrenia

1 reference

12 December 2020

Abnormal distributions of T-lymphocyte subsets in the cerebrospinal fluid of patients with acute schizophrenia

1 reference

12 December 2020

Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia

1 reference

12 December 2020

Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status

1 reference

12 December 2020

The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence

1 reference

12 December 2020

Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: markers of vulnerability or disease?

1 reference

12 December 2020

No evidence for autoimmunity in schizophrenia

1 reference

12 December 2020

Association of white blood cell subfraction concentration with fitness and fatness

1 reference

12 December 2020

Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia

1 reference

12 December 2020

Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes

1 reference

12 December 2020

Current antipsychotic dose correlates to mononuclear cell counts in the cerebrospinal fluid of psychotic patients

1 reference

12 December 2020

Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients

1 reference

12 December 2020

The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms

1 reference

12 December 2020

Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia

1 reference

12 December 2020

Search for atypical lymphocytes in schizophrenia

1 reference

12 December 2020

Endogenous psychoses and T and B lymphocytes

1 reference

12 December 2020

Lymphocyte subpopulations in peripheral blood from schizophrenic patients

1 reference

12 December 2020

An analysis of lymphocyte subpopulations in schizophrenic patients

1 reference

12 December 2020

T lymphocytes in schizophrenia

1 reference

12 December 2020

Depression and immunity. Lymphocyte function in ambulatory depressed patients, hospitalized schizophrenic patients, and patients hospitalized for herniorrhaphy

1 reference

12 December 2020

Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production

1 reference

12 December 2020

T-lymphocyte subpopulations in schizophrenic patients

1 reference

12 December 2020

Cellular immunity in schizophrenic patients before and during neuroleptic treatment

1 reference

12 December 2020

Elevation of CD5+ B lymphocytes in schizophrenia

1 reference

12 December 2020

T-cell subsets in schizophrenia: a comparison between drug-naive first episode patients and chronic schizophrenic patients

1 reference

12 December 2020

ABNORMAL LEUKOCYTES IN SCHIZOPHRENIA

1 reference

12 December 2020

Lymphocytes in schizophrenic patients under therapy: serological, morphological and cell subset findings

1 reference

12 December 2020

T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment

1 reference

12 December 2020

[Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication]

1 reference

12 December 2020

13. Early intervention with neuroleptics may decrease the l long-term morbidity of schizophrenia

1 reference

12 December 2020

10.1016/J.BIOPSYCH.2012.09.007

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

1 reference